MA46454A - Procédé multi-protéase - Google Patents

Procédé multi-protéase

Info

Publication number
MA46454A
MA46454A MA046454A MA46454A MA46454A MA 46454 A MA46454 A MA 46454A MA 046454 A MA046454 A MA 046454A MA 46454 A MA46454 A MA 46454A MA 46454 A MA46454 A MA 46454A
Authority
MA
Morocco
Prior art keywords
protease process
protease
Prior art date
Application number
MA046454A
Other languages
English (en)
Inventor
Max Davidson
Jessica Hägglund
Owe Orwar
Carolina Trkulja
Original Assignee
Oblique Therapeutics Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oblique Therapeutics Ab filed Critical Oblique Therapeutics Ab
Publication of MA46454A publication Critical patent/MA46454A/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in epitope analysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2560/00—Chemical aspects of mass spectrometric analysis of biological material

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Enzymes And Modification Thereof (AREA)
MA046454A 2016-10-06 2017-10-06 Procédé multi-protéase MA46454A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1617002.9A GB201617002D0 (en) 2016-10-06 2016-10-06 Multi-protease method

Publications (1)

Publication Number Publication Date
MA46454A true MA46454A (fr) 2019-08-14

Family

ID=57610568

Family Applications (1)

Application Number Title Priority Date Filing Date
MA046454A MA46454A (fr) 2016-10-06 2017-10-06 Procédé multi-protéase

Country Status (15)

Country Link
US (1) US11408883B2 (fr)
EP (1) EP3523659B1 (fr)
JP (1) JP7046931B2 (fr)
KR (1) KR102411384B1 (fr)
CN (1) CN109891247B (fr)
AU (1) AU2017339096B2 (fr)
BR (1) BR112019006624A2 (fr)
CA (1) CA3039064A1 (fr)
ES (1) ES2994658T3 (fr)
GB (1) GB201617002D0 (fr)
IL (1) IL265612B2 (fr)
MA (1) MA46454A (fr)
MX (1) MX2019003908A (fr)
NZ (1) NZ752437A (fr)
WO (1) WO2018065599A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA41842A (fr) 2015-03-31 2018-02-06 Oblique Therapeutics Ab Nouveaux procédés de sélection d'épitope
GB201918103D0 (en) * 2019-12-10 2020-01-22 Oblique Therapeutics Ab Epitopes and antibodies
CN113501869B (zh) * 2020-03-23 2026-06-23 浙江京新药业股份有限公司 具有创面修复作用的肽
CN114853855B (zh) * 2022-04-14 2023-06-20 安徽省华信生物药业股份有限公司 一种具有促降血糖激素glp-1分泌作用的富铬酵母活性肽

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69133049T2 (de) 1990-10-18 2003-01-02 Cancerforskningsfonden Af 1989 (Fonden Til Fremme Af Eksperimental Cancerforskning), Kopenhagen Antikörper gegen den urokinaserezeptor und ihre verwendung
IL117483A (en) 1995-03-17 2008-03-20 Bernard Brodeur MENINGITIDIS NEISSERIA shell protein is resistant to proteinase K.
IL138946A0 (en) * 2000-10-11 2001-11-25 Compugen Ltd Method for the identification of peptides and proteins
CA2453406A1 (fr) 2001-07-13 2003-01-23 Merck Patent Gesellschaft Mit Beschraenkter Haftung Procedes permettant la reduction de l'antigenicite de polypeptides
US7632686B2 (en) 2002-10-03 2009-12-15 Anderson Forschung Group High sensitivity quantitation of peptides by mass spectrometry
AU2003287017B2 (en) * 2002-10-03 2011-10-06 Norman Leigh Anderson High sensitivity quantitation of peptides by mass spectrometry
UA97086C2 (uk) 2003-07-15 2012-01-10 Емджен, Інк. Виділене людське антитіло, яке специфічно зв'язується з фактором росту нервової тканини (ngf)
WO2005074923A1 (fr) 2004-02-03 2005-08-18 Agt Biosciences Limited Methodes et compositions
WO2006005472A1 (fr) 2004-07-15 2006-01-19 Bayer Healthcare Ag Diagnostics et therapies de maladies associees au recepteur vanilloide (vr1)
US20060292639A1 (en) 2004-08-13 2006-12-28 Adolor Corporation Splice variant of the vanilloid receptor VR1A
WO2006047417A2 (fr) 2004-10-21 2006-05-04 University Of Florida Research Foundation, Inc. Detection de biomarqueurs du recepteur cannabinoide et utilisations
SE0403139D0 (sv) 2004-12-23 2004-12-23 Nanoxis Ab Device and use thereof
JP2008175814A (ja) 2006-12-21 2008-07-31 Eisai R & D Management Co Ltd 尿中タンパク質分子の検出・定量による糖尿病性腎症の検査方法及びそれに使用するキット
JP5555846B2 (ja) 2007-03-30 2014-07-23 国立大学法人山口大学 急性中枢神経障害の予後判定方法
CN102089430B (zh) 2008-05-09 2015-02-04 Abbvie公司 针对渐进性糖化终极产物受体(rage)的抗体及其用途
WO2010096385A2 (fr) * 2009-02-17 2010-08-26 The Regents Of The University Of Colorado, A Body Corporate, A Colorado Non-Profit Procédés et compositions pour le traitement des maladies auto-immunes
US9234037B2 (en) 2009-10-27 2016-01-12 Ucb Biopharma Sprl Method to generate antibodies to ion channels
US9383367B1 (en) 2010-12-07 2016-07-05 Chunli Liu Methods of detecting conjugation site-specific and hidden epitope/antigen
US9476888B2 (en) * 2011-08-08 2016-10-25 Syddansk Universitet Method and antibodies for the identification of ubiquitinated proteins and sites of ubiquitination
MA41842A (fr) * 2015-03-31 2018-02-06 Oblique Therapeutics Ab Nouveaux procédés de sélection d'épitope

Also Published As

Publication number Publication date
CN109891247B (zh) 2022-10-04
EP3523659A1 (fr) 2019-08-14
US20200041499A1 (en) 2020-02-06
AU2017339096B2 (en) 2023-03-30
NZ752437A (en) 2022-12-23
IL265612B2 (en) 2024-04-01
KR20190062504A (ko) 2019-06-05
WO2018065599A1 (fr) 2018-04-12
IL265612B1 (en) 2023-12-01
ES2994658T3 (en) 2025-01-28
IL265612A (en) 2019-05-30
GB201617002D0 (en) 2016-11-23
KR102411384B1 (ko) 2022-06-20
EP3523659B1 (fr) 2024-08-14
EP3523659C0 (fr) 2024-08-14
RU2019108573A (ru) 2020-11-06
MX2019003908A (es) 2019-06-10
US11408883B2 (en) 2022-08-09
CN109891247A (zh) 2019-06-14
CA3039064A1 (fr) 2018-04-12
AU2017339096A1 (en) 2019-05-02
JP2020502482A (ja) 2020-01-23
BR112019006624A2 (pt) 2019-07-02
RU2019108573A3 (fr) 2021-01-21
JP7046931B2 (ja) 2022-04-04

Similar Documents

Publication Publication Date Title
EP3564866A4 (fr) Procédé de calcul
EP3302794A4 (fr) Procédé d'époxydation
DK3405321T3 (da) Formstøbningsfremgangsmåde
DK3341479T3 (da) LNA-G-Proces
ES2864754T8 (es) Método de producción de metionina
HUE057118T2 (hu) Folyamat
SI3167011T1 (sl) Postopek sušenja
EP3265120C0 (fr) Procédé
EP3380628A4 (fr) Procédé de broyage
EP3412623A4 (fr) Procédé de purification
PT3256546T (pt) Processo de despolimerização
EP3361237A4 (fr) Procédé de tomographie
EP3184557C0 (fr) Procédé de préparation de polybutène
EP3704551A4 (fr) Procédé de production distribuée
EP3308154A4 (fr) Procédé de déconvolution
HUE044577T2 (hu) Eljárás karbamid elõállítására
EP3753693C0 (fr) Procédé de prédécoupe de troncs
EP3724710C0 (fr) Lunette de procédé
EP3523659C0 (fr) Procédé multi-protéase
EP3441464A4 (fr) Procédé de production de caroténoïde
MA42658A (fr) Procédé de réduction de pathogènes
EP3697821A4 (fr) Procédé
EP3558903A4 (fr) Procédé
EP3689852A4 (fr) Procédé de production de dihydroxyindoles
EP3705473A4 (fr) Procédé de production de dihydroxyindoles